Your session is about to expire
← Back to Search
Diagnostic Test
SIngle Arm for Cystic Fibrosis (CFALD Trial)
N/A
Waitlist Available
Led By Quais Mujawar
Research Sponsored by University of Manitoba
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
CFALD Trial Summary
Diagnosis of hepatic fibrosis is challenging as specific tests for detection of fibrosis in pediatric Cystic Fibrosis associated liver disease (CFALD) have not been developed and existing investigations do not correlate well with presence or severity of disease. Using a Liver biopsy it is difficult to diagnose this condition because of the patchy nature of the disease. Investigators intend to identify hepatic and pancreatic fibrosis in Cystic Fibrosis patients using Elastography and correlate this with their biochemical markers as well as histological findings of patients who have undergone liver biopsy for diagnosis of CFALD.
Eligible Conditions
- Cystic Fibrosis
- Cystic Fibrosis Liver Disease
CFALD Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Evaluate the diagnostic properties of Shear wave Elastography
Secondary outcome measures
To compare findings/fibrosis of Transient Elastography vs ElastPQ
To compare the pancreatic insufficiency/ fecal elastase and transient elastography from pancreas.
CFALD Trial Design
1Treatment groups
Experimental Treatment
Group I: SIngle ArmExperimental Treatment1 Intervention
All patients undergo Elastography. This is a single arm study
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Elastography
2011
N/A
~720
Find a Location
Who is running the clinical trial?
University of ManitobaLead Sponsor
595 Previous Clinical Trials
199,466 Total Patients Enrolled
Quais MujawarPrincipal InvestigatorUniversity of Manitoba
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger